Abstract:The study was designed to evaluate some cellular immune index of HIV infected participants. For the study, 80 HIV infected participants were recruited for the study. They were aged 15 - 55 years. 45 of these participants were classified as Symptomatic HIV (Stage 11), while the remaining 35 were Asymptomatic HIV (Stage 1). Similarly, 40 HIV seronegative participants served as Control. Blood samples collected from the participants were used HIV screening and confirmation, CD4+ T cell count, absolute lymphocyte c… Show more
“…The results of this study suggest that plasma albumin level has the potential to be used as a surrogate prognostic marker for HIV-1 disease monitoring because of a signi icant increase in plasma albumin level at 12 months of therapy. This inding is supported by Ifeanyichukwu et al (2011);Sharma et al (2016) that low plasma albumin in HAART naive participants may be due to acutephase responses in HIV-1 infection leading to a wide range of pathophysiological reactions that resulted in increased levels of in lammatory biomarkers such as tumor necrosis factor (TNF) and interleukin-6 (IL-6), which are responsible for the reduction in hepatic albumin synthesis and increase in albumin leakage to the extravascular space while enhanc-ing the degradation of albumin. In a similar study by Ifeanyichukwu et al (2011), it was shown that HIV-1 infection is accompanied by a robust plasma pro-in lammatory and anti-in lammatory cytokine response in HAART naive individuals.…”
Section: Discussionmentioning
confidence: 97%
“…This inding is supported by Ifeanyichukwu et al (2011);Sharma et al (2016) that low plasma albumin in HAART naive participants may be due to acutephase responses in HIV-1 infection leading to a wide range of pathophysiological reactions that resulted in increased levels of in lammatory biomarkers such as tumor necrosis factor (TNF) and interleukin-6 (IL-6), which are responsible for the reduction in hepatic albumin synthesis and increase in albumin leakage to the extravascular space while enhanc-ing the degradation of albumin. In a similar study by Ifeanyichukwu et al (2011), it was shown that HIV-1 infection is accompanied by a robust plasma pro-in lammatory and anti-in lammatory cytokine response in HAART naive individuals. The high proin lammatory cytokines were probably produced by monocytes and macrophages to initiate in lammation which is essential for the development of innate immunity, while the increased anti-in lammatory cytokines were stimulated probably to deactivate the activities of the pro-in lammatory cytokines.…”
Section: Discussionmentioning
confidence: 97%
“…This is because the lipoprotein lipase enzyme is inactive until it becomes bound to its cofactor, apoprotein C II (AP o C II ). And activation of the immune system in HIV-1 infection promotes pro-in lammatory cytokines synthesis and release that leads to the poor synthesis of apoprotein C II from the liver and, in turn, affects the activation of lipoprotein lipase (Ifeanyichukwu et al, 2011). From another study, it has been reported that immune system activation in HIV-1 infection causes a knockdown of AP o A −1 and AP o C II expression due to elevations of interferon-gamma (IFNr) and tumor necrosis factor-α (TNFα) that promotes lipids peroxidation and disturbances in the metabolism of lipids (Cunha et al, 2015); these lead to lipodystrophy, myositis and hepatomegaly.…”
Section: Discussionmentioning
confidence: 99%
“…Human immunode iciency virus infection has the ability to progressively shut down the host immune system due to the exponential growth of the virus in some infected individuals (Ifeanyichukwu et al, 2011). This may result in the manifestation of acquired immune de iciency syndrome (AIDS) if HIV progression in a host is not check meted (Ifeanyichukwu et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Despite vigorous researches and prophylactic mea-sures on HIV/AIDS, the infection and the disease conditions continue to threaten the lives of millions of people in Africa (Ifeanyichukwu et al, 2011). The continued surge of HIV/AIDS in Africa can be attributed to the in luence of so many other factors on the pathogenesis of the disease condition.…”
This was a cross-sectional study aimed to evaluate the use of albumin, hepatic lipase (HL) and lipoprotein lipase (LPL) enzyme as predictive markers of treatment failure in HIV-1 infected individuals. 154 participants {40 (group A), 35 (group B) on antiretroviral drugs (Test group) and 79 (group C) HIV naive participants (Control group)} aged 18 and 65 years were randomly recruited. Blood sample was collected from each test participant 6 months apart and once from control for determination of Albumin, HL, LPL, viral load (VL), CD4+ cells count. VL was significantly decreased while, Albumin, HL and LPL activities were significantly higher in test participants when compared with control P ≤ 0.05 respectively). Biochemical markers in test participants at 6 months of therapy were significantly lower compared with 12 months of therapy (P ≤ 0.05). Albumin and VL correlated positively with CD4 count while, lamivudine, nevirapine, tenofovir, HL, LPL correlated strongly and negatively with VL (P < 0.05 respectively). The high sensitivities and positive predictive value of albumin showed their predictive superiority over CD4+ count, HL, LPL and antiretroviral drug concentrations.The study thus, concludes that hypoalbuminemia with decreased HL and LPL activities were associated with unsuppressed viral load above 1000 copies/ml. This suggests that albumin; HL and LPL are good biochemical markers for prediction of treatment failure or success in participants on antiretroviral drugs.
“…The results of this study suggest that plasma albumin level has the potential to be used as a surrogate prognostic marker for HIV-1 disease monitoring because of a signi icant increase in plasma albumin level at 12 months of therapy. This inding is supported by Ifeanyichukwu et al (2011);Sharma et al (2016) that low plasma albumin in HAART naive participants may be due to acutephase responses in HIV-1 infection leading to a wide range of pathophysiological reactions that resulted in increased levels of in lammatory biomarkers such as tumor necrosis factor (TNF) and interleukin-6 (IL-6), which are responsible for the reduction in hepatic albumin synthesis and increase in albumin leakage to the extravascular space while enhanc-ing the degradation of albumin. In a similar study by Ifeanyichukwu et al (2011), it was shown that HIV-1 infection is accompanied by a robust plasma pro-in lammatory and anti-in lammatory cytokine response in HAART naive individuals.…”
Section: Discussionmentioning
confidence: 97%
“…This inding is supported by Ifeanyichukwu et al (2011);Sharma et al (2016) that low plasma albumin in HAART naive participants may be due to acutephase responses in HIV-1 infection leading to a wide range of pathophysiological reactions that resulted in increased levels of in lammatory biomarkers such as tumor necrosis factor (TNF) and interleukin-6 (IL-6), which are responsible for the reduction in hepatic albumin synthesis and increase in albumin leakage to the extravascular space while enhanc-ing the degradation of albumin. In a similar study by Ifeanyichukwu et al (2011), it was shown that HIV-1 infection is accompanied by a robust plasma pro-in lammatory and anti-in lammatory cytokine response in HAART naive individuals. The high proin lammatory cytokines were probably produced by monocytes and macrophages to initiate in lammation which is essential for the development of innate immunity, while the increased anti-in lammatory cytokines were stimulated probably to deactivate the activities of the pro-in lammatory cytokines.…”
Section: Discussionmentioning
confidence: 97%
“…This is because the lipoprotein lipase enzyme is inactive until it becomes bound to its cofactor, apoprotein C II (AP o C II ). And activation of the immune system in HIV-1 infection promotes pro-in lammatory cytokines synthesis and release that leads to the poor synthesis of apoprotein C II from the liver and, in turn, affects the activation of lipoprotein lipase (Ifeanyichukwu et al, 2011). From another study, it has been reported that immune system activation in HIV-1 infection causes a knockdown of AP o A −1 and AP o C II expression due to elevations of interferon-gamma (IFNr) and tumor necrosis factor-α (TNFα) that promotes lipids peroxidation and disturbances in the metabolism of lipids (Cunha et al, 2015); these lead to lipodystrophy, myositis and hepatomegaly.…”
Section: Discussionmentioning
confidence: 99%
“…Human immunode iciency virus infection has the ability to progressively shut down the host immune system due to the exponential growth of the virus in some infected individuals (Ifeanyichukwu et al, 2011). This may result in the manifestation of acquired immune de iciency syndrome (AIDS) if HIV progression in a host is not check meted (Ifeanyichukwu et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Despite vigorous researches and prophylactic mea-sures on HIV/AIDS, the infection and the disease conditions continue to threaten the lives of millions of people in Africa (Ifeanyichukwu et al, 2011). The continued surge of HIV/AIDS in Africa can be attributed to the in luence of so many other factors on the pathogenesis of the disease condition.…”
This was a cross-sectional study aimed to evaluate the use of albumin, hepatic lipase (HL) and lipoprotein lipase (LPL) enzyme as predictive markers of treatment failure in HIV-1 infected individuals. 154 participants {40 (group A), 35 (group B) on antiretroviral drugs (Test group) and 79 (group C) HIV naive participants (Control group)} aged 18 and 65 years were randomly recruited. Blood sample was collected from each test participant 6 months apart and once from control for determination of Albumin, HL, LPL, viral load (VL), CD4+ cells count. VL was significantly decreased while, Albumin, HL and LPL activities were significantly higher in test participants when compared with control P ≤ 0.05 respectively). Biochemical markers in test participants at 6 months of therapy were significantly lower compared with 12 months of therapy (P ≤ 0.05). Albumin and VL correlated positively with CD4 count while, lamivudine, nevirapine, tenofovir, HL, LPL correlated strongly and negatively with VL (P < 0.05 respectively). The high sensitivities and positive predictive value of albumin showed their predictive superiority over CD4+ count, HL, LPL and antiretroviral drug concentrations.The study thus, concludes that hypoalbuminemia with decreased HL and LPL activities were associated with unsuppressed viral load above 1000 copies/ml. This suggests that albumin; HL and LPL are good biochemical markers for prediction of treatment failure or success in participants on antiretroviral drugs.
Human immunodeficiency virus (HIV) is associated with altered metabolism and increased energy expenditure, this energy requirement increases significantly as the HIV disease progresses. This study aimed on the use of Adenosine triphosphate (ATP), Guanosine triphosphate (GTP), Adenosine diphosphate (ADP) and Adenosine monophosphate (AMP) as an index of energy utilization, storage and energy balance in HIV infected individuals. This is a longitudinal, prospective, case-controlled study involving seventy seven (77) HIV Sero-positive individuals newly diagnosed attending retroviral disease treatment centre of Nnamdi Azikiwe University University Teaching Hospital (NAUTH) aged 18-60 years both male and female not on highly active antiretroviral therapy (HAART), were enrolled in the study as test subjects and thirty six (36) apparently healthy HIV Sero-negative individuals both male and female as control subjects. ATP, GTP, ADP and AMP were estimated by enzyme linked immunosorbent assay (ELISA), while, total Energy Balance was determined by calculation. The data obtained were subjected to statistical analysis using SPSS software application (version 21.0) and the results expressed as mean ± standard deviation. The plasma ATP and GTP were significantly lower (P<0.05) in both HIV pre-treatment and post-treatment group compared with control group. Meanwhile, the plasma level of ADP and AMP were significantly lower (P<0.05) in HIV post-treatment group compared with HIV pre-treatment and control group. There was also a significant difference (P<0.05) in ATP, ADP, AMP and GTP level between HIV pre-treatment and post-treatment group. Meanwhile, the energy balance was lower (P<0.05) in HIV groups compared with control group. However, the energy balance in HIV post-treatment group was significantly lower (P<0.05) compared to HIV pre- treatment group. In conclusion, the significant changes in the biochemical parameters measured suggest altered metabolism, increased energy expenditure and energy deficit/negative energy balance in HIV subjects resulting from increased energy expenditure. Hence, High energy molecules such ATP, ADP, GTP and AMP can be used to predict early energy deficit and manage energy imbalance in HIV infected individuals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.